Danilo DAlessandro's Insider Trades & SAST Disclosures
Danilo DAlessandro's most recent trade in ClearPoint Neuro Inc was a trade of 16,313 Restricted Stock Units done . Disclosure was reported to the exchange on March 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Danilo DAlessandro.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 16,313 | 65,253 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 16,313 | 79,030 (0%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.18 per share. | 12 Mar 2025 | 8,284 | 70,746 (0%) | 0% | 13.2 | 109,183 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 4,146 | 4,145 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 4,146 | 64,823 (0%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.70 per share. | 11 Mar 2025 | 2,106 | 62,717 (0%) | 0% | 12.7 | 26,746 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 18,765 | 18,765 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 18,765 | 70,206 (0%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.19 per share. | 06 Mar 2025 | 9,529 | 60,677 (0%) | 0% | 13.2 | 125,688 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 51,660 | 51,660 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 4.53 per share. | 31 Dec 2024 | 1,949 | 51,441 (0%) | 0% | 4.5 | 8,829 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.26 per share. | 20 Aug 2024 | 1,191 | 49,492 (0%) | 0% | 11.3 | 13,411 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 4.58 per share. | 28 Jun 2024 | 1,913 | 50,683 (0%) | 0% | 4.6 | 8,762 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.74 per share. | 10 Jun 2024 | 4,824 | 48,770 (0%) | 0% | 5.7 | 27,690 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 81,566 | 81,566 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 8,291 | 8,291 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 9,383 | 37,530 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 9,383 | 58,312 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.24 per share. | 06 Mar 2024 | 4,718 | 53,594 (0%) | 0% | 6.2 | 29,440 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 5.77 per share. | 29 Dec 2023 | 1,479 | 48,929 (0%) | 0% | 5.8 | 8,534 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.34 per share. | 20 Aug 2023 | 1,166 | 52,408 (0%) | 0% | 5.3 | 6,226 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 6.15 per share. | 30 Jun 2023 | 1,371 | 53,574 (0%) | 0% | 6.2 | 8,432 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. | 10 Jun 2023 | 2,526 | 52,203 (0%) | 0% | 6.9 | 17,455 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 46,913 | 46,913 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 15,637 | 15,637 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Other type of transaction at price $ 7.20 per share. | 31 Dec 2022 | 1,252 | 54,729 (0%) | 0% | 7.2 | 9,014 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.23 per share. | 29 Sep 2022 | 4,958 | 53,477 (0%) | 0% | 10.2 | 50,720 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.24 per share. | 20 Aug 2022 | 583 | 58,435 (0%) | 0% | 13.2 | 7,719 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 23,400 | 58,214 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 15,600 | 15,600 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.22 per share. | 29 Sep 2021 | 4,958 | 33,465 (0%) | 0% | 17.2 | 85,377 | Common Stock |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 11,750 | 11,750 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 5,875 | 38,423 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2020 | 75,000 | 75,000 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2020 | 30,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2020 | 4,310 | 34,310 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Danilo DAlessandro | Vice President, Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.80 per share. | 29 Sep 2020 | 1,762 | 32,548 (0%) | 0% | 5.8 | 10,220 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges